Cargando…
COPD in Germany: Use of Diagnostic Measures Including Blood Eosinophil Counts in Daily Practice
Background Accumulating evidence on the role of blood eosinophils as a biomarker prompted the Global Initiative for Chronic Obstructive Lung Disease (GOLD) committee to refine the existing treatment algorithm by incorporating eosinophil counts into treatment recommendations. However, there is a lac...
Autores principales: | Greulich, T., Töpfer, V., Hennig, M., Orehounig, C. C., Ams, K., Mohrlang, C. D., Killian, P. H., Kardos, P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Georg Thieme Verlag KG
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8093015/ https://www.ncbi.nlm.nih.gov/pubmed/33307557 http://dx.doi.org/10.1055/a-1266-6602 |
Ejemplares similares
-
Longitudinal stability of blood eosinophil count strata in the COPD COSYCONET cohort
por: Greulich, Timm, et al.
Publicado: (2018) -
Blood eosinophil count as a prognostic biomarker in COPD
por: Oh, Yeon-Mok, et al.
Publicado: (2018) -
Variability of blood eosinophil count and prognosis of COPD exacerbations
por: Martínez-Gestoso, Sandra, et al.
Publicado: (2021) -
Blood eosinophil count and airway epithelial transcriptome relationships in COPD versus asthma
por: George, Leena, et al.
Publicado: (2019) -
Association between blood eosinophil count and small airway eosinophils in smokers with and without COPD
por: Maetani, Tomoki, et al.
Publicado: (2023)